10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
Syndax Pharmaceuticals Inc (SNDX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kynam Capital Derrick Tang | 5,842,925 | $112,476,306 | +3% | 8.62% |
| 2. | Eversept Partners Kamran Moghtaderi | 4,105,313 | $79,027,275 | +14% | 5.41% |
| 3. | VenBio Select Advisor Kurt Von Emster | 3,888,437 | $74,852,412 | 1.09% | |
| 4. | Point72 Asset Management Steve Cohen | 2,778,267 | $53,481,635 | -1% | 0.13% |
| 5. | Avidity Partners Management David Witzke And Michael Gregory | 2,455,000 | $47,258,750 | -27% | 2.41% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.03 | 1,250 | 52,623 | 2024-06-14 | Filing | ||
| $15.46 | 500 | 15,666 | 2021-04-26 | Filing | ||
| $14.11 | 13,967 | 43,300 | 2021-04-22 | Filing | ||
| $8.00 | 12,500 | 43,900 | 2020-02-04 | Filing | ||
| $5.40 | 11,000 | 31,400 | 2019-10-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.27 | 52,855 | 17,836 | 2023-08-09 | Filing | ||
| $20.45 | 24,000 | 48,000 | 2023-08-02 | Filing | ||
| $20.46 | 24,000 | 48,000 | 2023-08-02 | Filing | ||
| $20.46 | 35,000 | 48,000 | 2023-08-02 | Filing | ||
| $20.40 | 52,855 | 17,836 | 2023-07-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,585,221 | $163,916,627 | 0.03% | |
| 2. | 7,015,548 | $151,605,991 | 0% | |
| 3. | 5,016,224 | $108,400,601 | 0% | |
| 4. | 4,335,353 | $93,686,978 | 0% | |
| 5. | 1,664,306 | $35,965,653 | 0% |
News See All
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Third Quarter 2024 Earnings Conference Call. Today's call is being recorded. All participants have been placed in a listen-only mode.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Second Quarter 2024 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2024 Earnings Conference Call. Today's call is being recorded.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2023 Earnings Call Transcript
Syndax Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1 EPS, expectations were $-0.99.
12 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the 12 most promising cancer stocks according to analysts.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Third Quarter 2023 Earnings Conference Call. Today's call is being recorded.